FDA Approved: DUAVEE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Duavee (conjugated estrogens/bazedoxifene) to update the labeling, potentially expanding its approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis
• Vasomotor Symptoms

Drugs mentioned

• Duavee (bazedoxifene/conjugated estrogens)

Snippet

SUPPL AP for DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE)